CardioFocus, Inc., a medical device company dedicated to advancing pulsed field ablation (PFA) treatment for cardiac arrhythmias, announced major advancements across its PFA portfolio. OptiShot (TM) - ...
OptiShot ultra-compliant balloon enables tissue contact and precise anatomic delivery of pulsed energy for treatment of atrial fibrillation in first European patients MARLBOROUGH, Mass.--(BUSINESS ...
CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, today announced the first series of patients treated with the investigational OptiShot(TM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results